Purificación Martínez del Prado
0000-0002-9153-6972
Publication & Citation Trends
Publications
0 total
Rucaparib maintenance in ATHENA-MONO (GOG-3020/ENGOT-ov45) in patients with newly diagnosed advanced ovarian cancer: exploratory post-progression evaluations for patients with HRD-negative and HRD-unknown tumours
Cited by 0
Semantic Scholar
INTERVENTIONS TO IMPROVE SATISFACTION AFTER A GERIATRIC ASSESSMENT IN PATIENTS WITH LUNG CANCER
Cited by 0
Semantic Scholar
Treatment and long-term clinical outcomes of incidental pulmonary embolism in cancer patients: an international prospective cohort study
Cited by 0
Semantic Scholar
Risk model for clinically relevant neutropenic event among patients with non hematological tumors receiving chemotherapy regimens not classified as high-risk for febrile neutropenia: results from a multicenter prospective cohort study (NEURISK) OA
Cited by 0
Semantic Scholar
Budget impact analysis of the 21-gene assay (Oncotype DX® breast cancer) for the breast cancer treatment in the Basque country OA
Cited by 1
Semantic Scholar
Abstract P2-13-17: Impact on survival of primary tumor resection in women with de novo metastatic breast cancer. The GEICAM Alamo I-III breast cancer registry (1990-2001)
Cited by 0
Semantic Scholar
Impact of the Intermediate Oncotype DX Recurrence Score results on adjuvant treatment recommendations in hormone receptor-positive early breast cancer in a single center.
Cited by 1
Semantic Scholar
2147 Pathological response as a prognostic factor for disease free survival on colorectal cancer with liver limited disease
Cited by 0
Semantic Scholar
Research Topics
Breast Cancer Treatment Studies
(12)
Venous Thromboembolism Diagnosis and Management
(10)
Cancer Treatment and Pharmacology
(10)
HER2/EGFR in Cancer Research
(7)
Advanced Breast Cancer Therapies
(7)
Affiliations
Roche (Switzerland)
Uppsala University Hospital
Universitat de València
Hospital de Basurto
Spanish Society of Family and Community Medicine